Effects of vitamin D supplementation on insulin resistance and cardiometabolic risk factors in children with metabolic syndrome: a triple-masked controlled trial
Tài liệu tham khảo
da Conceição-Machado, 2013, Hypertriglyceridemic waist phenotype: association with metabolic abnormalities in adolescents, J Pediatr (Rio J)., 89, 56, 10.1016/j.jped.2013.02.009
Kelishadi, 2007, Childhood overweight, obesity, and the metabolic syndrome in developing countries, Epidemiol Rev., 29, 62, 10.1093/epirev/mxm003
Kelishadi, 2006, Paediatric metabolic syndrome and associated anthropometric indices: the CASPIAN Study, Acta Paediatr., 95, 1625, 10.1080/08035250600750072
Khashayar, 2013, Metabolic Syndrome and Cardiovascular Risk Factors in a National Sample of Adolescent Population in the Middle East and North Africa: the CASPIAN III Study, Int J Endocrinol., 2013, 702095, 10.1155/2013/702095
Patel, 2012, Vitamin D in cardiovascular disease, Int J Prev Med., 3, 664
Boucher, 2011, Vitamin D insufficiency and diabetes risks, Curr Drug Targets., 12, 61, 10.2174/138945011793591653
Salo, 2011, Relationship of vitamin D status and cardiometabolic risk factors in children and adolescents, Pediatr Endocrinol Rev., 9, 456
Harris, 2012, A randomized, placebo- controlled trial of vitamin D supplementation to improve glycaemia in overweight and obese African Americans, Diabetes Obes Metab., 14, 789, 10.1111/j.1463-1326.2012.01605.x
Borghi, 2006, Construction of the World Health Organization child growth standards: selection of methods for attained growth curves, Stat Med., 25, 247, 10.1002/sim.2227
Kahn, 2005, American Diabetes Association; European Association for the Study of Diabetes. The metabolic syndrome: time for a critical appraisal: joint statement from the American Diabetes Association and the European Association for the Study of Diabetes, Diabetes Care., 28, 2289, 10.2337/diacare.28.9.2289
Shafiee, 2013, First report on validity of a continuous metabolic syndrome score as an indicator for metabolic syndrome in a national sample of pediatric population: the CASPIAN-III Study, Endocrynol Polska., 10.5603/EP.2013.0006
Kelishadi, 2009, Lifestyle and environmental factors associated with inflammation, oxidative stress and insulin resistance in children, Atherosclerosis., 203, 311, 10.1016/j.atherosclerosis.2008.06.022
Expert, 2011, Pediatrics., 128, S213, 10.1542/peds.2009-2107C
Holick, 2007, Vitamin D deficiency, N Engl J Med., 357, 266, 10.1056/NEJMra070553
Nam, 2012, 25-Hydroxyvitamin D insufficiency is associated with cardiometabolic risk in Korean adolescents: the 2008-2009 Korea National Health and Nutrition Examination Survey (KNHANES), Public Health Nutr., 1
Pacifico, 2011, Low 25(OH)D3 levels are associated with total adiposity, metabolic syndrome, and hypertension in Caucasian children and adolescents, Eur J Endocrinol., 165, 603, 10.1530/EJE-11-0545
Ganji, 2011, Serum 25-hydroxyvitamin D concentrations are associated with prevalence of metabolic syndrome and various cardiometabolic risk factors in US children and adolescents based on assay- adjusted serum 25-hydroxyvitamin D data from NHANES 2001-2006, Am J Clin Nutr., 94, 225, 10.3945/ajcn.111.013516
Petchey, 2009, The role of 25-hydroxyvitamin D deficiency in promoting insulin resistance and inflammation in patients with chronic kidney disease: a randomised controlled trial, BMC Nephrol., 10, 41, 10.1186/1471-2369-10-41
Park, 2012, Association of serum 25-hydroxyvitamin D levels with markers for metabolic syndrome in the elderly: a repeated measure analysis, J Korean Med Sci., 27, 653, 10.3346/jkms.2012.27.6.653
Muldowney, 2011, Relationships between vitamin D status and cardio-metabolic risk factors in young European adults, Ann Nutr Metab., 58, 85, 10.1159/000324600
Delvin, 2011, Importance of vitamin D in insulin resistance, Bull Acad Natl Med., 195, 1091
Chacko, 2011, Serum 25-hydroxyvitamin D concentrations in relation to cardiometabolic risk factors and metabolic syndrome in postmenopausal women, Am J Clin Nutr., 94, 209, 10.3945/ajcn.110.010272
Salekzamani, 2011, Is vitamin D status a determining factor for metabolic syndrome?. A case-control study, Diabetes Metab Syndr Obes., 4, 205
Al-Daghri, 2012, Modest reversal of metabolic syndrome manifestations with vitamin D status correction: a 12-month prospective study, Metabolism., 61, 661, 10.1016/j.metabol.2011.09.017
Ford, 2005, Concentrations of serum vitamin D and the metabolic syndrome among U.S. adults, Diabetes Care., 28, 1228, 10.2337/diacare.28.5.1228
Brenner, 2011, Plasma vitamin D levels and risk of metabolic syndrome in Canadians, Clin Invest Med., 34, E377, 10.25011/cim.v34i6.15899
Witham, 2010, The effect of different doses of vitamin D(3) on markers of vascular health in patients with type 2 diabetes: a randomised controlled trial, Diabetologia., 53, 2112, 10.1007/s00125-010-1838-1
Eftekhari, 2011, Impact of treatment with oral calcitriol on glucose indices in type 2 diabetes mellitus patients, Asia Pac J Clin Nutr., 20, 521
Erdönmez, 2011, No relationship between vitamin D status and insulin resistance in a group of high school students, J Clin Res Pediatr Endocrinol., 3, 198, 10.4274/jcrpe.507
Cavalier, 2013, A randomised, double- blinded, placebo-controlled, parallel study of vitamin D3 supplementation with different schemes based on multiples of 25,000 IU doses, Int J Endocrinol., 2013, 327265, 10.1155/2013/327265